Hologic, Inc.HOLXNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank29
3Y CAGR-16.9%
5Y CAGR-8.8%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-16.9%/yr
vs +60.6%/yr prior
5Y CAGR
-8.8%/yr
Recent deceleration
Acceleration
-77.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 24.97% | -22.4% |
| 2024 | 32.16% | +16.7% |
| 2023 | 27.56% | -36.6% |
| 2022 | 43.46% | -14.5% |
| 2021 | 50.81% | +28.4% |
| 2020 | 39.57% | +285.0% |
| 2019 | 10.28% | +57.2% |
| 2018 | 6.54% | -89.1% |
| 2017 | 59.92% | +63.8% |
| 2016 | 36.57% | - |